title: Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
authors.affiliation: Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors.forename: Yvette N
authors.initials: YN
authors.lastname: Martin
authors.forename: Janet E
authors.initials: JE
authors.lastname: Olson
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
authors.forename: Robert A
authors.initials: RA
authors.lastname: Vierkant
authors.forename: Zachary S
authors.initials: ZS
authors.lastname: Fredericksen
authors.forename: V Shane
authors.initials: VS
authors.lastname: Pankratz
authors.forename: Yanhong
authors.initials: Y
authors.lastname: Wu
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Schaid
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Sellers
authors.forename: Richard M
authors.initials: RM
authors.lastname: Weinshilboum
mesh_terms: D000483:Alleles; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D005091:Exons; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D015233:Models, Statistical; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012306:Risk
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2)